Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
المزيد من أخبار الأعمال
Restaurant Brands reports mixed results as Burger King's U.S. turnaround shows signs of success
Burger King's U.S. restaurants outperformed, while Popeyes disappointed.
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
FedEx beats expectations, raises outlook in first report since calendar adjustment
FedEx on Wednesday beat Wall Street expectations on the top and bottom lines for the third quarter of its newly aligned fiscal year.
Chipotle earnings miss estimates, but same-store sales increase for third straight quarter
For the full year, Chipotle reiterated its previous forecast that its same-store sales will increase by a low single digit percentage.